Cynomolgus LILRB4/ILT-3/CD85k protein (Recombinant) (C-His) (STJP020283)
SPECIFICATIONS
HostHEK293 cells
ConjugationUnconjugated
ImmunogenRecombinant Cynomolgus LILRB4/ILT-3/CD85k Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Gln22-Glu259) of Cynomolgus LILRB4 fused with His tag at the C-terminus.
General Information
| Short Description | Recombinant-Cynomolgus LILRB4/ILT-3/CD85k-C-His protein was developed in hek293 cells using the region Gln22-Glu259. For use in research applications. |
| Host | HEK293 cells |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Conjugation | Unconjugated |
| Storage Instruction | Store at-20ยฐC for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method | < 1 EU/Mu g of the protein by LAL method. |
Target Information
| Immunogen | Recombinant Cynomolgus LILRB4/ILT-3/CD85k Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Gln22-Glu259) of Cynomolgus LILRB4 fused with His tag at the C-terminus. |
| Immunogen Region | Gln22-Glu259 |
Additional Info
| Background | LILRB4, also known as CD85k and LIR-5, ILT3, ? is an approximately 60 kDa transmembrane glycoprotein that negatively regulates immune cell activation. Mature human ILT3 consists of a 238 amino acid (aa) extracellular domain with two Ig-like domains, a 21 aa transmembrane segment, and a 168 aa cytoplasmic domain with 3 immunoreceptor tyrosine-based inhibitory motifs (ITIM).LILRB4 is receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles. |
Information sourced from Uniprot.org